2025
Universal parent-focused child sexual abuse prevention: A quasi-experimental protocol
Abourjaily E, Guastaferro K, McElwee K, Connell C. Universal parent-focused child sexual abuse prevention: A quasi-experimental protocol. PLOS ONE 2025, 20: e0314459. PMID: 39820171, PMCID: PMC11737775, DOI: 10.1371/journal.pone.0314459.Peer-Reviewed Original ResearchConceptsChild sexual abusePrimary prevention interventionsPrimary prevention effortsSignificant public health concernQuasi-experimental designChild sexual abuse riskPublic health concernPrevention workshopPreventive interventionsPreventive behaviorsExperimental groupPrevention effortsSurvey 2Prevention strategiesRecruitment materialsSurvey 1Survey assessmentsSexual abuseHealth concernParental engagementProtective behaviorsAffected childrenFollow-upSurveyChildren
2024
Financial Toxicity Among Patients With Advanced Solid Tumors Participating in Early-Phase Clinical Trials
Blanter J, Van Hyfte G, Ahmad M, Xu S, Hapanowicz O, Fazilov G, Lu A, Lucas N, Wu K, Shelton G, DeMerchant M, Lachowicz M, Kier M, Werner M, Eder J, Galsky M, Marron T, Smith C, LoRusso P, Hofstatter E, Doroshow D. Financial Toxicity Among Patients With Advanced Solid Tumors Participating in Early-Phase Clinical Trials. JCO Oncology Practice 2024, 21: 862-875. PMID: 39661920, DOI: 10.1200/op.24.00293.Peer-Reviewed Original ResearchEarly-phase clinical trialsSolid tumorsClinical trialsAssociated with higher FTFinancial toxicityBarriers to clinical trial enrollmentAdvanced solid malignanciesAdvanced solid tumorsInverse association with ageBaseline to 2 monthsYale Cancer CenterCOST scoreClinical trial enrollmentProspective survey studySolid malignanciesNo significant differenceBaseline FTTime of consentNovel therapiesPrimary outcomeCancer CenterSurvey 1Trial enrollmentPatientsEarly-phase
2023
Tracking antimalarial drug resistance using mosquito blood meals: a cross-sectional study
Ehrlich H, Somé A, Bazié T, Ebou C, Dembélé E, Balma R, Goodwin J, Wade M, Bei A, Ouédraogo J, Foy B, Dabiré R, Parikh S. Tracking antimalarial drug resistance using mosquito blood meals: a cross-sectional study. The Lancet Microbe 2023, 4: e461-e469. PMID: 37086737, PMCID: PMC10365133, DOI: 10.1016/s2666-5247(23)00063-0.Peer-Reviewed Original ResearchConceptsMosquito blood mealsAntimalarial drug resistanceSurvey 3Blood-fed mosquitoesBlood samplesSurvey 1Survey 2Blood mealDrug resistanceUltrasensitive quantitative PCRHuman blood samplesCross-sectional studyMargin of equivalenceStrong surveillance systemCross-sectional surveySupplementary Materials sectionMarker of clonalityPragmatic thresholdAntimalarial resistanceDrug susceptibilityInfectious diseasesPlasmodium falciparumNational InstituteTolerabilityMaterial section
2015
Interobserver and Intraobserver Reliability of the Modified Waldenström Classification System for Staging of Legg-Calvé-Perthes Disease
Hyman J, Trupia E, Wright M, Matsumoto H, Jo C, Mulpuri K, Joseph B, Kim H, Casey V, Castañeda P, Choi P, de Barros F, Gilbert S, Gourineni P, Hennessey T, Herring J, Janicki J, Kelly D, Kessler J, Larson A, Laine J, Logan K, Mack P, Martin B, Mehlman C, Otsuka N, Rosenfeld S, Sankar W, Schrader T, Shore B, Stuecker R, Sundberg S, Tamai J, Tis J, White K. Interobserver and Intraobserver Reliability of the Modified Waldenström Classification System for Staging of Legg-Calvé-Perthes Disease. Journal Of Bone And Joint Surgery 2015, 97: 643-650. PMID: 25878308, DOI: 10.2106/jbjs.n.00887.Peer-Reviewed Original ResearchConceptsLegg-Calve-Perthes diseaseIntraobserver reliabilityAssociated with clinical outcomesLegg-Calve-PerthesKappa valuesRadiographs of patientsSurvey 1Interobserver kappa valuesPediatric orthopaedic surgeonsClinical outcomesIntraobserver agreementClassification systemSurvey 3Orthopaedic surgeonsSurgeonsDiseaseOutcome studies
2005
Impact of the cancer risk intake system on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy
Skinner CS, Rawl SM, Moser BK, Buchanan AH, Scott LL, Champion VL, Schildkraut JM, Parmigiani G, Clark S, Lobach DF, Bastian LA. Impact of the cancer risk intake system on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy. Journal Of General Internal Medicine 2005, 20: 360-365. PMID: 15857495, PMCID: PMC1490091, DOI: 10.1111/j.1525-1497.2005.40115.x.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAlgorithmsAntineoplastic Agents, HormonalBreast NeoplasmsColonic NeoplasmsColonoscopyCommunicationCounselingFemaleGenetic CounselingHumansMaleMiddle AgedOdds RatioOvarian NeoplasmsPatient Acceptance of Health CarePatient Education as TopicPhysician-Patient RelationsPrimary Health CareRisk AssessmentTamoxifenConceptsPatient-clinician discussionsPrimary care settingCare settingsGenetic counselingBaseline telephone surveyObjective cancer riskMonths postvisitClinic visitsCancer riskTelephone surveyColonoscopySurvey 1TamoxifenPretest-posttest designGreater proportionComputerized programCounselingManagement recommendationsRisk management recommendationsParticipantsPostvisitFollowProportionSettingBaseline
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply